Overview

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 474121 in the Blood

Status:
Completed
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to investigate the effect on the exposure of BI 474121 in plasma when given as oral single dose together with multiple oral doses of itraconazole (Test, T) as compared to when given alone as oral single dose (Reference, R).
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Itraconazole